Immunocore Holdings plc: basic weighted-average shares
Basic weighted-average shares for Immunocore Holdings plc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Immunocore Holdings plc financial histories
What this measure means
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
Exact concept: us-gaap:WeightedAverageNumberOfSharesOutstandingBasic. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2021-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Reading these values
This selected numerical history matches Diluted weighted-average shares for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 50,345,666 | shares | 2026-02-25 | 10-K · 0001671927-26-000005 |
| 2024-01-01 | 2024-12-31 | 49,991,064 | shares | 2026-02-25 | 10-K · 0001671927-26-000005 |
| 2023-01-01 | 2023-12-31 | 48,888,975 | shares | 2026-02-25 | 10-K · 0001671927-26-000005 |
| 2022-01-01 | 2022-12-31 | 45,714,923 | shares | 2025-02-26 | 10-K · 0001671927-25-000006 |
| 2021-01-01 | 2021-12-31 | 42,488,579 | shares | 2024-02-28 | 10-K · 0001140361-24-009921 |
Related financial histories
- Immunocore Holdings plc: total assets
- Immunocore Holdings plc: total liabilities
- Immunocore Holdings plc: stockholders equity
- Immunocore Holdings plc: cash and cash equivalents
- Immunocore Holdings plc: net income or loss
- Immunocore Holdings plc: operating cash flow
- Immunocore Holdings plc: capital expenditure payments
- Immunocore Holdings plc: revenue
- Immunocore Holdings plc: contract revenue excluding tax
- Immunocore Holdings plc: financing cash flow
- Immunocore Holdings plc: investing cash flow
- Immunocore Holdings plc: retained earnings or deficit
- Immunocore Holdings plc: diluted weighted-average shares
- Immunocore Holdings plc: basic earnings per share
- Immunocore Holdings plc: diluted earnings per share
- Immunocore Holdings plc: income tax expense or benefit
- Immunocore Holdings plc: net property, plant and equipment
- Immunocore Holdings plc: share-based compensation expense
- Immunocore Holdings plc: operating income or loss
- Immunocore Holdings plc: current assets
- Immunocore Holdings plc: interest expense
- Immunocore Holdings plc: current liabilities
- Immunocore Holdings plc: current accounts payable
- Immunocore Holdings plc: net current accounts receivable
- Immunocore Holdings plc: net inventory
- Immunocore Holdings plc: cost of revenue
- Immunocore Holdings plc: selling, general and administrative expense
- Immunocore Holdings plc: research and development expense
Inspect the source
- Entity
- Immunocore Holdings plc / CIK 0001671927
- Captured
- 2026-09-21T17:24:22.867Z
- SEC response SHA-256
9b9a725e0bbccd98d18f051ca64838816cde2b50de1afd7df9a2a28f1cd4d7ea
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001671927.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))